[EN] ANTAGONISTS OF CB1 RECEPTOR.<br/>[FR] ANTAGONISTES DU RÉCEPTEUR CB1
申请人:INST NAT SANTE RECH MED
公开号:WO2012160006A1
公开(公告)日:2012-11-29
The invention relates to an antagonist of CB1 receptor for use in the treatment of a pathologic condition or disorder selected from the group consisting of bladder and gastrointestinal disorders; inflammatory diseases; cardiovascular diseases; nephropathies; glaucoma; spasticity; cancer; osteoporosis; metabolic disorders; obesity; addiction, dependence, abuse and relapse related disorders; psychiatric and neurological disorders; neurodegenerative disorders; autoimmune hepatitis and encephalitis; pain; reproductive disorders and skin inflammatory and fibrotic diseases.
LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME
申请人:Sony Corporation
公开号:EP2385420A1
公开(公告)日:2011-11-09
A method of manufacturing a liquid crystal display device with which response characteristics are able to be easily improved without using major equipment is provided. The method of manufacturing a liquid crystal display device includes steps of forming a first alignment film 22 composed of a polymer compound having a crosslinkable functional group as a side chain on one substrate of a pair of substrates 20 and 30; forming a second alignment film 32 on the other substrate of the pair of substrates 20 and 30; arranging the pair of substrates 20 and 30 so that the first alignment film 22 and the second alignment film 32 are opposed to each other, and sealing a liquid crystal layer 40 containing a liquid crystal molecule 41 having negative dielectric constant anisotropy between the first alignment film 22 and the second alignment film 32; and bridging the polymer compound to give pretilt to the liquid crystal molecule 41 after sealing the liquid crystal layer 40.